Rare but Urgent: Emerging Targets and Biomarkers in Vulvar Cancer episode artwork

EPISODE · Feb 2, 2026 · 19 MIN

Rare but Urgent: Emerging Targets and Biomarkers in Vulvar Cancer

from GOSH Podcast · host Gynecologic Cancer Initiative

New GOSH episode out now! 🎙️ On this episode, we are joined by Dr. Madeline Rhind, a medical oncology fellow at BC Cancer, to discuss her work on druggable targets and prognostic biomarkers in vulvar squamous cell carcinoma. The conversation highlights challenges in rare cancer research and the importance of translating molecular discoveries into clinical care. Tune in now at the link in our bio! #vulvarcancer #gynecancer #bccancer For more information on the Gynecologic Cancer Initiative, please visit https://gynecancerinitiative.ca/ or email us at [email protected]  Where to learn more about us:  Twitter – @GCI_Cluster Instagram – @gynecancerinitiative Facebook – facebook.com/gynecancerinitiativeTikTok – @gci_gosh

Episode metadata supplied by the publisher feed · Published Feb 2, 2026

Embed this episode

Ready to play

Rare but Urgent: Emerging Targets and Biomarkers in Vulvar Cancer

0:00 19:27

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of GOSH Podcast?

This episode is 19 minutes long.

When was this GOSH Podcast episode published?

This episode was published on February 2, 2026.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this GOSH Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!